- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06286891
Frailty, Physical Capacity and Lung Function in Postoperative Pulmonary Endarterectomy Patients
May 1, 2024 updated by: Rafael M. Ianotti, PT, University of Sao Paulo General Hospital
Evaluation of Frailty, Physical Capacity and Lung Function in Postoperative Pulmonary Endarterectomy Patients: an Observational and Prospective Clinical Study
The goal of this observational and prospective study is to investigate changes in physical performance, lung function, respiratory and peripheral muscle strength in patients during the postoperative period following pulmonary endarterectomy (PET).
Study Overview
Status
Recruiting
Detailed Description
This study aims to investigate the physical changes in patients undergoing pulmonary endarterectomy (PET).
It will observe alterations in physical performance, lung function, and muscle strength during the postoperative period.
This study, observational and prospective, will include individuals aged ≥18 scheduled, evaluating them preoperatively, post-intensive care unit discharge, before hospital discharge and after six months .
Assessments involve tests like the Six-minute walk test, Short Physical Performance Battery, One-minute sit-to-stand test, manovacuometry, dynamometry, spirometry and Clinical Frailty Scale to identify frailty and measure muscle and lung function.
The study also aims to explore predictive variables for functional loss during hospitalization.
Study Type
Observational
Enrollment (Estimated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Rafael M Ianotti, PT
- Phone Number: +55 11 26615319
- Email: rafael.ianotti@hc.fm.usp.br
Study Locations
-
-
SP
-
São Paulo, SP, Brazil, 05403-000
- Recruiting
- Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
-
Sub-Investigator:
- Orival Freitas Filho, MD
-
Sub-Investigator:
- Fabio B Jatene, MD,PhD
-
Sub-Investigator:
- Kelly CO Abud, PT, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patients in the preoperative period of elective pulmonary endarterectomy susrgery.
Description
Inclusion Criteria:
- Age ≥ 18 years
- Both genders
- Elective pulmonary endarterectomy surgery
- Absence of cognitive or peripheral motor impairment that prevents the performance of functional tests in the preoperative period.
Exclusion Criteria:
- Reoperation for any reason
- Presence of cognitive or peripheral motor impairment that prevents the performance of functional tests in the postoperative period.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To investigate changes in physical performance measured by Six-Minute Walk Test.
Time Frame: Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery.
|
Measures: the assessment will take place in a flat 30-meter corridor, marked every 1 meter with non-slip flooring, and the patient will be instructed to walk for six minutes as fast as possible.
|
Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery.
|
To investigate changes in physical performance measured by Short Physical Performance Battery (SPPB).
Time Frame: Baseline (one day before the surgery), after the surgery (the day immediately after ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after surgery.
|
Measure: global score
|
Baseline (one day before the surgery), after the surgery (the day immediately after ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after surgery.
|
To investigate changes in physical performance by 1-minute sit-to-stand test (1-MSTST).
Time Frame: Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery
|
Measure: number of 1-MSTST repetitions.
|
Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery
|
To investigate changes in peripheral muscle strength.
Time Frame: Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery
|
Measure: hand grip strengh (Kgf).
|
Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery
|
To investigate changes in respiratory muscle strength:
Time Frame: Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery
|
Measures: manovacuometry (cmH2O)
|
Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery
|
To investigate changes in lung function test measure by spirometry:
Time Frame: Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery
|
Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery
|
|
To investigate frailty by Clinical Frailty Scale (CFS)
Time Frame: Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery
|
The minimal value is 1 and the maximal is 9 in which the lowest scores mean worse outcomes.
|
Baseline (one day before the surgery), after the surgery (the day immediately ICU discharge), before the hospital discharge (an average of 20 days) and 6 months after the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To explore potential preoperative and immediate postoperative risk factors as predictors of functional loss.
Time Frame: Baseline (one day before the surgery) during the immediate postoperative period.
|
Measures: Occurrence of comorbidities and clinical variables associated with functional decline.
|
Baseline (one day before the surgery) during the immediate postoperative period.
|
To investigate changes in hemodynamic and respiratory variables during the funcional tests.
Time Frame: Immediateley before and after each functional test.
|
Immediateley before and after each functional test.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Rafael M Ianotti, PT, Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 29, 2024
Primary Completion (Estimated)
November 1, 2024
Study Completion (Estimated)
September 30, 2025
Study Registration Dates
First Submitted
February 8, 2024
First Submitted That Met QC Criteria
February 23, 2024
First Posted (Actual)
February 29, 2024
Study Record Updates
Last Update Posted (Estimated)
May 2, 2024
Last Update Submitted That Met QC Criteria
May 1, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAAE: 73520523.7.0000.0068
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Disability
-
University of Alabama at BirminghamRecruitingDisability Physical | Physical InactivityUnited States
-
Assistance Publique - Hôpitaux de ParisTerminatedPhysical Activity | Physical DisabilityFrance
-
Washington University School of MedicineRecruitingPhysical DisabilityUnited States
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
University of Alabama at BirminghamRecruiting
-
Johns Hopkins UniversityNational Institute on Aging (NIA)RecruitingDisability PhysicalUnited States
-
Washington University School of MedicineNational Institute on Disability, Independent Living, and Rehabilitation...Active, not recruiting
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedDisability PhysicalUnited States
-
University of Colorado, DenverCompletedPhysical DisabilityUnited States
-
University of Alabama at BirminghamNational Institute on Disability, Independent Living, and Rehabilitation...Completed